Äèñêóññèîííûé Êëóá

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ïñèõîòåðàïèÿ, ïñèõèàòðèÿ è íàðêîëîãèÿ > Îáùåíèå ñïåöèàëèñòîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 14.08.2008, 20:22
Àâàòàð äëÿ APTEM
APTEM APTEM âíå ôîðóìà Ïîë ìóæñêîé
çàáàíåí
 
Ðåãèñòðàöèÿ: 25.01.2007
Ãîðîä: Õàáàðîâñê
Ñîîáùåíèé: 610
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 33 ðàç(à) çà 29 ñîîáùåíèé
APTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAPTEM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íåò, õîñïèñîâ íåò. Íî äåòñêèå îíêîãåìàòîëîãè÷åñêèå îòäåëåíèÿ, ê ñîæàëåíèþ, â ÷åì-òî èõ çàìåíÿþò. Òàêîå îòäåëåíèå ó íàñ åñòü, è èíîãäà, ê ñîæàëåíèþ â âèäå ðàçîâûõ àêöèé, òàì óñòðàèâàþò òàêèå ïðàçäíèêè äëÿ äåòåé.
Ïîääåðæèâàþ âàøó òî÷êó çðåíèÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #17  
Ñòàðûé 31.08.2008, 21:03
Shadrov
Ãîñòü
 
Ñîîáùåíèé: n/a
Öèòàòà: Gilev: "À ñêàçêîòåðàïèþ ìîæíî îáñóäèòü, òåìà èíòåðåñíàÿ, íî ê ìåòîäàì ëå÷åíèÿ øèçîôðåíèè îíà îòíîøåíèÿ íå èìååò".

Êàê îòäåëüíûé ìåòîä, êîíå÷íî íå èìååò, íî â êîìïëåêñå ïðèìåíÿþò, êàê è ìíîãèå äðóãèå àðò-òåðàïåâòè÷åñêèå ïðèåìû. Èçâåñòåí áîëüøîé îïûò êëèíèêè Ìåíòåðøâàéãå â Ìþíõåíå.  èíñòèòóòå Áåõòåðåâà â Ïåòåðáóðãå ýòèì çàíèìàþòñÿ ïîä ðóêîâîäñòâîì ïðîô. Â.Ä.Âèäà - îòäåëåíèå â îñíîâíîì äëÿ áîëüíûõ ñ ýíäîãåííûìè ïñèõîçàìè - òàì öåëàÿ "áàòàðåÿ" àðò-òåðàïåâòè÷åñêèõ ãðóïï: òåàòð-, òàíö-, ìèëèå-, ðèòìî-...
Îá ýòîì ìîæíî ÷èòàòü Ãþíòåðà Àììîíà è, êñòàòè, Â.Ä.Âèä, "Ïñèõîòåðàïèÿ øèçîôðåíèè".

Êîììåíòàðèè ê ñîîáùåíèþ:
pliz îäîáðèë(à):
Divisenko îäîáðèë(à):
Psychiatr îäîáðèë(à): À åñëè áû Âû åù¸ ññûëêè íà ýâèäåíñû ïî àðòòåðàïèè âûëîæèëè, òî áûë áû îäîáðÿìñ ñ +
Îòâåòèòü ñ öèòèðîâàíèåì
  #18  
Ñòàðûé 01.09.2008, 13:03
Àâàòàð äëÿ Gilev
Gilev Gilev âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 31.12.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 809
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 97 ðàç(à) çà 97 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 1
Gilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êíèãó èíòåðåñíî ïî÷èòàòü, ëþáèìà ìíîãèìè àíòèïñèõèàòðàìè, îñîáåííî Âèä Â.Ä. - "Ïñèõîàíàëèòè÷åñêàÿ ïñèõîòåðàïèÿ ïðè øèçîôðåíèè". Äîâîëüíî ìíîãî êðèòèêè ìåäèêàìåíòîçíîãî ëå÷åíèÿ è ïðåóâåëè÷åíèå ðîëè ïñèõîòåðàïèè. Õîòÿ ñàì îí äåëàåò âûâîä, ÷òî ïñèõîòåðàïèÿ íà èñõîäû çàáîëåâàíèÿ, à â ïðèíöèïå è íà åãî òå÷åíèå, âëèÿíèÿ íå îêàçûâàåò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #19  
Ñòàðûé 01.09.2008, 13:14
Shadrov
Ãîñòü
 
Ñîîáùåíèé: n/a
Öèòàòà:
Ñîîáùåíèå îò Gilev Ïîñìîòðåòü ñîîáùåíèå
ïñèõîòåðàïèÿ íà èñõîäû çàáîëåâàíèÿ, à â ïðèíöèïå è íà åãî òå÷åíèå, âëèÿíèÿ íå îêàçûâàåò.
Íî îêàçûâàåò âëèÿíèå íà ÷àñòîòó ðåöèäèâîâ, êîìïëàåíñ...

Êîììåíòàðèè ê ñîîáùåíèþ:
bill îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #20  
Ñòàðûé 01.09.2008, 13:32
Àâàòàð äëÿ Gilev
Gilev Gilev âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 31.12.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 809
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 97 ðàç(à) çà 97 ñîîáùåíèé
Çàïèñåé â äíåâíèêå: 1
Gilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïñèõîàíàëèç ïðè øèçîôðåíèè âëèÿåò íà ÷àñòîòó ðåöèäèâîâ? À èññëåäîâàíèÿ ïîäòâåðæäàþùèå ýòî åñòü?
Îòâåòèòü ñ öèòèðîâàíèåì
  #21  
Ñòàðûé 02.09.2008, 09:40
Shadrov
Ãîñòü
 
Ñîîáùåíèé: n/a
Öèòàòà:
Ñîîáùåíèå îò Gilev Ïîñìîòðåòü ñîîáùåíèå
Ïñèõîàíàëèç ïðè øèçîôðåíèè âëèÿåò íà ÷àñòîòó ðåöèäèâîâ? À èññëåäîâàíèÿ ïîäòâåðæäàþùèå ýòî åñòü?
ß íå ãîâîðþ èìåííî ïðî ïñèõîàíàëèç.  îñíîâíîì ïðèìåíÿåòñÿ èíäèâèäóàëüíàÿ è ãðóïïîâàÿ ïñèõîòåðàïèÿ, íàïðàâëåííàÿ íà âûÿâëåíèå è ïðåîäîëåíèå íåàäàïòèâíûõ ñòðàòåãèé ïîâåäåíèÿ, ïñèõîëîãè÷åñêèõ çàùèò, ïðåäëàãàþòñÿ ïîâåäåí÷åñêèå ïðèåìû â îáùåíèè, çîíäèðóåòñÿ ñåìåéíàÿ îáñòàíîâêà, ïî âîçìîæíîñòè ïðèâëåêàþòñÿ ðîäñòâåííèêè, êðîìå òîãî îáðàçîâàòåëüíûé êîìïîíåíò - ÷òîá ïàöèåíò è åãî áëèçêèå çíàëè, ÷òî ýòî çà áîëåçíü, ÷òî îò íåå æäàòü è êàê ëå÷èòüñÿ. Òàêàÿ ðàáîòà äåéñòâèòåëüíî ñíèæàåò ÷àñòîòó ðåöèäèâîâ. Èññëåäîâàíèÿ, ïîäòâåðæäàþùèå ýòî, ïðèâåäåíû, íàïðèìåð, â "Ïñèõîòåðàïèè øèçîôðåíèè" Â.Ä.Âèäà.
http://www.piter.com/attachment.php?...747&at=exc&n=0

Êîììåíòàðèè ê ñîîáùåíèþ:
FRSM îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #22  
Ñòàðûé 02.09.2008, 12:14
Shadrov
Ãîñòü
 
Ñîîáùåíèé: n/a
Psychiatr îäîáðèë(à): À åñëè áû Âû åù¸ ññûëêè íà ýâèäåíñû ïî àðòòåðàïèè âûëîæèëè, òî áûë áû îäîáðÿìñ ñ +

Âîò, íàïðèìåð, ñàéò êëèíèêè Ìåíòåðøâàéãå. http://www.klinik-menterschwaige.de/ ß ïî-íåìåöêè íå î÷åíü, íî òàì ìîæíî íàéòè êîå-÷òî.
Åñòü åùå êíèãà "Î÷åðêè äèíàìè÷åñêîé ïñèõèàòðèè. Îïûò òðàíñêóëüòóðàëüíîãî èññëåäîâàíèÿ", åå ìîæíî ñêà÷àòü çäåñü: http://www.zipsites.ru/psy/psylib/info.php?p=2696
×àñòü îãëàâëåíèÿ:
7. Òåðàïåâòè÷åñêèå ìåòîäû â äèíàìè÷åñêîé ïñèõèàòðèè Ã. Àììîíà
7.1. Ìåòîäû ïñèõîòåðàïåâòè÷åñêîãî âîçäåéñòâèÿ
7.1.1. Ìèëèå-òåðàïèÿ (òåðàïèÿ ñðåäîé)
7.1.2. Èíäèâèäóàëüíàÿ è ãðóïïîâàÿ ïñèõîòåðàïèÿ
7.1.3. Òàíöòåðàïèÿ
7.1.4. Ìóçûêîòåðàïèÿ
7.1.5. Àðòòåðàïèÿ (òåðàïèÿ æèâîïèñüþ)
7.1.6. Òåàòðòåðàïèÿ
7.1.7. Òåðàïèÿ âåðõîâîé åçäîé
7.1.8. Òåðàïåâòè÷åñêèå àñïåêòû áîëüøîé ãðóïïû
7.1.9. Äðóãèå âèäû òåðàïèè
Îòâåòèòü ñ öèòèðîâàíèåì
  #23  
Ñòàðûé 02.09.2008, 12:45
Àâàòàð äëÿ Psychiatr
Psychiatr Psychiatr âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.05.2006
Ãîðîä: ã. Äîíåöê, Óêðàèíà
Ñîîáùåíèé: 871
Ïîáëàãîäàðèëè 21 ðàç(à) çà 20 ñîîáùåíèé
Psychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé êîëëåãà, Shadrov!
Ãîâîðÿ îá ýâèäåíñàõ, ÿ èìåë â âèäó íå÷òî ïîäîáíîå:
Öèòàòà:
1: Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003728.
Update of:
Cochrane Database Syst Rev. 2003;(2):CD003728.

Art therapy for schizophrenia or schizophrenia-like illnesses.
Ruddy R, Milnes D.

University of Leeds, Academic Unit of Psychiatry and Behavioural Sciences, 15 Hyde Terrace, Leeds, West Yorkshire, UK LS2 9LT. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

BACKGROUND: Many people with schizophrenia or schizophrenia-like illnesses continue to experience symptoms in spite of medication. In addition to medication, creative therapies, such as art therapy, may be helpful. Art therapy allows exploration of the patient's inner world in a non-threatening way through a therapeutic relationship and the use of art materials. It was mainly developed in adult psychiatric inpatient units and was designed for use with people for whom verbal psychotherapy would be impossible. OBJECTIVES: To review the effects of art therapy as an adjunctive treatment for schizophrenia compared with standard care and other psychosocial interventions. SEARCH STRATEGY: We updated the search of the Cochrane Schizophrenia Group's Register (February 2005), hand searched reference lists and 'Inscape' (the Journal of the British Association of Art Therapists), and contacted relevant authors. SELECTION CRITERIA: We included all randomised controlled trials that compared art therapy with standard care or other psychosocial interventions for schizophrenia. DATA COLLECTION AND ANALYSIS: We reliably selected, quality assessed and extracted data from the studies. We excluded data where more than 50% of participants in any group were lost to follow up. For continuous outcomes we calculated a weighted mean difference and its 95% confidence interval. For binary outcomes we calculated a fixed effects risk ratio (RR), its 95% confidence interval (CI) and a number needed to treat (NNT). MAIN RESULTS: The search identified 61 reports but only two studies (total n=137) met the inclusion criteria. Both compared art therapy plus standard care with standard care alone. More people completed the therapy if allocated to the art therapy group compared with standard care in the short (n=90, 1 RCT, RR 0.97 CI 0.41 to 2.29), medium (n=47, 1 RCT, RR 0.34 CI 0.15 to 0.80) and long term (n=47, 1 RCT, RR 0.96 CI 0.57 to 1.60). Data from one mental state measure (SANS) showed a small but significant difference favouring the art-therapy group (n=73, 1 RCT, WMD -2.3 CI -4.10 to -0.5). In the short term, a measure of social functioning (SFS) showed no clear difference between groups in endpoint scores (n=70, 1 RCT, WMD 7.20 CI -2.53 to 16.93) and quality of life, as measured by the PerQoL, did not indicate effects of art therapy (n=74, 1 RCT, WMD 0.1 CI -2.7 to 0.47). AUTHORS' CONCLUSIONS: Randomised studies are possible in this field. Further evaluation of the use of art therapy for serious mental illnesses is needed as its benefits or harms remain unclear.

PMID: 16235338 [PubMed - indexed for MEDLINE]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #24  
Ñòàðûé 02.09.2008, 21:37
Àâàòàð äëÿ Lyubimova
Lyubimova Lyubimova âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.12.2006
Ãîðîä: Online
Ñîîáùåíèé: 2,537
Ñêàçàë(à) ñïàñèáî: 76
Ïîáëàãîäàðèëè 177 ðàç(à) çà 146 ñîîáùåíèé
Lyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLyubimova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Post

Îíî æå:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Randomised studies are possible in this field. The use of drama therapy for schizophrenia and schizophrenia-like illnesses should continue to be under evaluation as its benefits, or harms, are unclear.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Music therapy as an addition to standard care helps people with schizophrenia to improve their global state and may also improve mental state and functioning if a sufficient number of music therapy sessions are provided. Further research should address the dose-effect relationship and the long-term effects of music therapy.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Currently trial based data on Morita therapy is inconclusive. Morita therapy for schizophrenia remains an experimental intervention, new trials are justified and specific outlines for design of future studies are outlined in additional tables.


[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
There is no clear evidence to suggest that compliance therapy is beneficial for people with schizophrenia and related syndromes but more randomised studies are justified and needed in order for this intervention to be fully examined.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
There are insufficient data to identify a difference in outcome between supportive therapy and standard care. There are several outcomes, including hospitalisation and general mental state, indicating advantages for other psychological therapies over supportive therapy but these findings are based on a few small studies.
Future research would benefit from larger trials that use supportive therapy as the main treatment arm rather than the comparator.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Evidence from trials suggests that psychoeducational approaches are useful as a part of the treatment programme for people with schizophrenia and related illness. The fact that the interventions are brief and inexpensive should make them attractive to managers and policy makers. More well-designed, conducted and reported randomised studies investigating the efficacy of psychoeducation are needed.



[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
We found insufficient evidence to recommend the use of acupuncture for people with schizophrenia. The numbers of participants and the blinding of acupuncture were both inadequate, and more comprehensive and better designed studies are needed to determine the effects of acupuncture for schizophrenia.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ayurvedic medication may have some effects for treatment of schizophrenia, but has been evaluated only in a few small pioneering trials.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Chinese herbal medicines, given in a Western biomedical context, may be beneficial for people with schizophrenia when combined with antipsychotics. Traditional Chinese medicine is also under-evaluated, but results from one pioneering study that attempted to evaluate TCM should encourage further trials.



[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
There ought to be further research of nicotine for schizophrenia by parallel group design randomised controlled trials investigating the effects of nicotine on symptoms of schizophrenia as well as on side effects of antipsychotic drugs. We further note that authors and journals should conform to the CONSORT guidelines when publishing the research articles, especially when disclosing all the data available from a particular study.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Results are inconclusive with most outcomes being either non-significant or producing contradictory findings. Currently, adjunctive DHEA should remain an experimental treatment for people with schizophrenia.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Adjunctive estrogen with or without progesterone does not appear to offer convincing advantages over placebo. Before any more research is undertaken in this area, all completed and unpublished work should be made available in order to ensure that more trials are justified.



[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
CBT is a promising but under evaluated intervention. Currently, trial-based data supporting the wide use of CBT for people with schizophrenia or other psychotic illnesses are far from conclusive. More trials are justified, especially in comparison with a lower grade supportive approach. These trials should be designed to be both clinically meaningful and widely applicable.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Data are inconclusive and provide no evidence for or against cognitive rehabilitation as a treatment for schizophrenia.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Clinicians, researchers, policy makers and recipients of care cannot be confident of the effects of family intervention from the findings of this review. Further data from already completed trials could greatly inform practice and more trials are justified as long as their participants, interventions and outcomes are applicable to routine care.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Current data do not support the use of psychodynamic psychotherapy techniques for hospitalised people with schizophrenia. If psychoanalytic therapy is being used for people with schizophrenia there is an urgent need for trials.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
The studies in this field are few, small, poorly reported and outdated. Hypnosis could be helpful for people with schizophrenia. If we are to find this out, better designed, conducted and reported randomised studies are required. This current update has not revealed any new studies in this area since 2003.


P.S. Schizophrenia: psychotherapy, psychological treatments, psychosocial treatments

Êîììåíòàðèè ê ñîîáùåíèþ:
BBC îäîáðèë(à):
Psychiatr îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #25  
Ñòàðûé 02.09.2008, 23:42
Àâàòàð äëÿ pliz
pliz pliz âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 22.11.2005
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 4,243
Ñêàçàë(à) ñïàñèáî: 34
Ïîáëàãîäàðèëè 562 ðàç(à) çà 532 ñîîáùåíèé
pliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåpliz ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êàêîé-òî ìðà÷íûé îáçîð "òîãî, ÷òî ëèáî íèêàê íå ïîìîãàåò, åñëè íå âðåäèò äëÿ ëå÷åíèÿ øèçîôðåíèè".Íàçâàíèå: icon_zoidberg.gif
Ïðîñìîòðîâ: 54

Ðàçìåð: 3.4 Êá
Äóìàþ ÷òî óïîìèíàíèå àêóïóíêòóðû áûëî èçëèøíèì â ïñè-ðàçäåëå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #26  
Ñòàðûé 03.09.2008, 07:21
Àâàòàð äëÿ Psychiatr
Psychiatr Psychiatr âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 22.05.2006
Ãîðîä: ã. Äîíåöê, Óêðàèíà
Ñîîáùåíèé: 871
Ïîáëàãîäàðèëè 21 ðàç(à) çà 20 ñîîáùåíèé
Psychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåPsychiatr ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò pliz Ïîñìîòðåòü ñîîáùåíèå
Êàêîé-òî ìðà÷íûé îáçîð "òîãî, ÷òî ëèáî íèêàê íå ïîìîãàåò, åñëè íå âðåäèò äëÿ ëå÷åíèÿ øèçîôðåíèè".
Íà ñàìîì äåëå, ϸòð Þðüåâè÷, íå âñ¸ òàê ïå÷àëüíî...
Öèòàòà:
What are the effects of drug treatments for positive and negative symptoms?
Trade off between benefits and harms:
Amisulpride
Chlorpromazine
Clozapine
Depot bromperidol decanoate
Depot haloperidol decanoate
Haloperidol
Loxapine
Molindone
Olanzapine
Pimozide
Quetiapine
Risperidone
Sulpiride
Ziprasidone
Zotepine

Unknown effectiveness:
Perazine

Which interventions reduce relapse rates?
Beneficial:
Continuation of antipsychotic drugs for at least 6 months after an acute episode
Multiple session family interventions
Psychoeducational interventions
Unknown effectiveness:
CBT
Social skills training

Which interventions are effective in people who are resistant to standard antipsychotic drugs?
Beneficial:
Clozapine (compared with standard antipsychotic drugs)
Unknown effectiveness:
Olanzapine (compared with standard antipyschotic drugs)

Which interventions improve adherence to antipsychotic medication?
Likely to be beneficial:
Behavioural therapy
Compliance therapy
Psychoeducational interventions
Unknown effectiveness:
Multiple session family interventions
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Ê òîìó æå, äëÿ âðà÷à îáëàäàíèå çíàíèåì òîãî, ÷òî ïîëåçíî, à ÷òî áåñïîëåçíî è äàæå âðåäíî, èìõî, ãîðàçäî ëó÷øå, ÷åì âèòàíèå â îáëàêàõ... Ïî êðàéíåé ìåðå, àäåêâàòíîå èñïîëüçîâàíèå ýòèõ çíàíèé âðà÷îì òî÷íî ëó÷øå äëÿ ïàöèåíòîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 11:14.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.